653962019	653962019	CD	B-NP	O
|	|	NN	I-NP	O
ARMC	ARMC	NN	I-NP	O
|	|	NN	I-NP	O
44888831	44888831	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9009414	9009414	CD	B-NP	O
|	|	CC	I-NP	O
10/14/2005	10/14/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2005	10/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
HONSINGER	HONSINGER	NN	B-NP	O
,	,	,	O	O
ANDREA	ANDREA	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
,	,	,	O	O
non-ST-elevation	non-ST-elevation	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
AND	AND	CC	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
since	since	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1995	1995	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Genuario	Genuario	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
44-year-old	44-year-old	JJ	I-NP	O
married	married	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ryans	Ryans	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
complaint	complaint	NN	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wife	wife	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
experiencing	experience	VBG	I-VP	O
gradually	gradually	RB	B-ADVP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
needing	need	VBG	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
a	a	DT	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
200/100	200/100	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
florid	florid	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
hypertensive	hypertensive	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
and	and	CC	I-NP	O
oxygenation	oxygenation	NN	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
R.f.	R.f.	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypertension	hypertension	NN	I-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
labetalol	labetalol	NN	B-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
a	a	DT	B-NP	O
successful	successful	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
nitroprusside	nitroprusside	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lopressor	Lopressor	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
EF	EF	NN	B-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
on	on	IN	B-PP	O
echocardiogram	echocardiogram	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
an	an	DT	B-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
frequently	frequently	RB	B-ADVP	O
agitated	agitate	VBN	B-VP	O
requiring	require	VBG	B-VP	O
increasing	increase	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Versed	Verse	VBN	B-NP	O
and	and	CC	I-NP	O
fentanyl	fentanyl	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
p.r.n.	p.r.n.	NN	B-NP	O
Haldol	Haldol	NNP	I-NP	O
and	and	CC	I-NP	O
Zyprexa	Zyprexa	NNP	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
Nymo	Nymo	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
lateral	lateral	JJ	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depressions	depression	NNS	I-NP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-ST-elevation	non-ST-elevation	JJ	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
430	430	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Integrilin	Integrilin	NN	B-NP	B-protein
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IH	IH	NN	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
Mancharl	Mancharl	NNP	I-NP	O
Tuvange	Tuvange	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
marked	marked	JJ	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
protocol	protocol	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
Ston	Ston	NNP	I-NP	O
N	N	NNP	I-NP	O
CCU	CCU	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
leak	leak	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
286	286	CD	B-NP	O
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
of	of	IN	B-PP	O
6.2	6.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
13.8	13.8	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
evolving	evolve	VBG	B-VP	O
anterior	anterior	JJ	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
while	while	IN	B-SBAR	O
Integrilin	Integrilin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
CCU	CCU	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PAMC	PAMC	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	I-VP	O
Norvasc	Norvasc	VB	I-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
25	25	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
50	50	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
on	on	IN	B-PP	O
CCU	CCU	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
and	and	CC	O	O
Nipride	Nipride	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Nipride	Nipride	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
sinus	sinus	NN	B-NP	O
pause	pause	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
2.5	2.5	CD	I-NP	O
seconds	second	NNS	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
labetalol	labetalol	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

CCU	CCU	NN	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
spiking	spike	VBG	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
104.1	104.1	CD	B-NP	O
on	on	IN	B-PP	O
CCU	CCU	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
broad	broad	JJ	B-NP	O
spectrum	spectrum	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
for	for	IN	B-PP	O
presumptive	presumptive	JJ	B-NP	O
ICU	ICU	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
CCU	CCU	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developing	develop	VBG	B-VP	O
left-sided	left-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
on	on	IN	B-PP	O
ICU	ICU	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
hypertension-induced	hypertension-induced	JJ	B-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
embolism	embolism	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
sources	source	NNS	I-NP	O
and	and	CC	I-NP	O
emboli	embolus	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
bubble	bubble	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Secondary	Secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
swallow	swallow	VB	I-VP	O
,	,	,	O	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
self-discontinued	self-discontinue	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
team	team	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
non-ST-elevation	non-ST-elevation	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Difficult	Difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
at	at	IN	B-PP	O
LCH	LCH	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
11.4	11.4	CD	B-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
ICU	ICU	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Home	Home	NN	B-NP	O
Medications	Medication	NNS	I-NP	O
:	:	:	O	O
Metformin	Metformin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Actos	Actos	NNP	B-NP	O
30	30	CD	B-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
TriCor	TriCor	NN	B-NP	O
145	145	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Aceon	Aceon	NN	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
acetabutolol	acetabutolol	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Tiazac	Tiazac	NN	B-NP	O
420	420	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Crestor	Crestor	NN	B-NP	O
20	20	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
Catapres-2	Catapres-2	NN	B-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Medications	Medication	NNS	B-NP	O
On	On	IN	B-PP	O
Transfer	Transfer	NNP	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
captopril	captopril	NN	B-NP	O
50	50	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
hydralazine	hydralazine	NN	B-NP	O
20	20	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
famotidine	famotidine	NN	B-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
senna	senna	NN	B-NP	O
;	;	:	O	O
heparin	heparin	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

day	day	NN	B-NP	O
#	#	#	B-NP	O
10	10	CD	I-NP	O
;	;	:	O	O
ceftazidime	ceftazidime	NN	B-NP	O
2	2	CD	I-NP	O
g	g	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

day	day	NN	B-NP	O
#	#	#	B-NP	O
7	7	CD	I-NP	O
;	;	:	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
750	750	CD	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
works	work	VBZ	B-VP	O
in	in	IN	B-PP	O
shipping	shipping	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
kids	kid	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
T-max	T-max	NN	B-NP	O
and	and	CC	O	O
T-current	T-current	JJ	B-NP	O
are	be	VBP	B-VP	O
100.9	100.9	CD	B-NP	O
;	;	:	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
138	138	CD	B-NP	O
to	to	TO	B-PP	O
190/72	190/72	CD	B-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
;	;	:	O	O
pulse	pulse	NN	B-NP	O
is	be	VBZ	B-VP	O
62	62	CD	B-NP	O
to	to	TO	B-PP	O
79	79	CD	B-NP	O
;	;	:	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
;	;	:	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	I-VP	O
agitated	agitate	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
answers	answer	NNS	B-NP	O
in	in	IN	B-PP	O
English	English	NNP	B-NP	O
and	and	CC	O	O
remembering	remember	VBG	B-VP	O
his	his	PRP$	B-NP	O
anniversary	anniversary	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
subconjunctival	subconjunctival	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Some	Some	DT	B-NP	O
mild	mild	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
airway	airway	NN	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
;	;	:	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
s2	s2	NN	I-NP	B-protein
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
;	;	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Slight	Slight	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
4/5	4/5	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Deep	Deep	NN	B-NP	B-protein
tendon	tendon	NN	I-NP	I-protein
reflex	reflex	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
and	and	CC	I-NP	O
symmetric	symmetric	JJ	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
are	be	VBP	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
142	142	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.0	4.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
111	111	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
26	26	CD	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
172	172	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
8.6	8.6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
29.2	29.2	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
200	200	CD	B-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
ST	ST	JJ	B-NP	O
abnormality	abnormality	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
subendocardial	subendocardial	JJ	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
echocardiogram	echocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
LV	LV	NN	B-NP	O
mildly	mildly	RB	B-ADVP	O
dilated	dilate	VBD	B-VP	O
concentric	concentric	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Function	Function	NN	B-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

EF	EF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

MRI/MRA	MRI/MRA	NN	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
infarctions	infarction	NNS	I-NP	O
;	;	:	O	O
one	one	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
cerebellum	cerebellum	NN	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
corpus	corpus	NN	I-NP	O
callosum	callosum	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
centrum	centrum	NN	I-NP	O
semiovale	semiovale	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
bilaterally	bilaterally	RB	B-NP	O
symmetric	symmetric	JJ	I-NP	O
kidneys	kidney	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

EEG	EEG	NN	B-NP	O
abnormal	abnormal	JJ	I-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-VP	O
diffuse	diffuse	VB	I-VP	O
cerebral	cerebral	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
toxic	toxic	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
definite	definite	JJ	I-NP	O
epileptiform	epileptiform	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showing	show	VBG	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
his	his	PRP$	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
cultures	culture	NNS	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
44-year-old	44-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
crisis	crisis	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
strokes	stroke	NNS	I-NP	O
and	and	CC	O	O
left-sided	left-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
non-ST-elevation	non-ST-elevation	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
likely	likely	RB	B-ADVP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
agitation	agitation	NN	I-NP	O
,	,	,	O	O
hyperglycemia	hyperglycemia	NN	B-NP	O
requiring	require	VBG	B-VP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
protocol	protocol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
ICU-acquired	ICU-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
spiking	spike	VBG	B-VP	O
fever	fever	NN	B-NP	O
needing	need	VBG	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
broad	broad	JJ	B-NP	O
spectrum	spectrum	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
showing	show	VBG	B-VP	O
sign	sign	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
evolving	evolve	VBG	I-NP	O
anterior	anterior	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
left	left	JJ	B-NP	B-protein
oblique	oblique	JJ	I-NP	I-protein
marginal	marginal	JJ	I-NP	I-protein
#	#	#	I-NP	I-protein
1	1	CD	I-NP	I-protein
with	with	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
DES	DES	NNP	I-NP	O
stent	stent	NN	I-NP	O
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-NP	O
postcatheterization	postcatheterization	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
high	high	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
captopril	captopril	NN	B-NP	O
50	50	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
eventually	eventually	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
hydralazine	hydralazine	NN	B-NP	O
20	20	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
IV	IV	CD	B-NP	O
,	,	,	O	O
eventually	eventually	RB	B-ADVP	O
switching	switch	VBG	B-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
medication	medication	NN	I-NP	O
of	of	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
patch	patch	NN	I-NP	O
as	as	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
labile	labile	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
sinus	sinus	NN	B-NP	O
pause	pause	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
3	3	CD	B-NP	O
seconds	second	NNS	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
episodes	episode	NNS	I-NP	O
since	since	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
versus	versus	IN	B-PP	O
conduction	conduction	NN	B-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

Electrophysiology	Electrophysiology	NN	B-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
EP	EP	NN	I-NP	O
service	service	NN	I-NP	O
encouraged	encourage	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
wear	wear	VB	I-VP	O
a	a	DT	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
device	device	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
sinus	sinus	NN	I-NP	O
pause	pause	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
with	with	IN	B-PP	O
atenolol	atenolol	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
transferred	transfer	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sedation	sedation	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
CCU	CCU	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
diuresed	diurese	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
spiked	spike	VBN	I-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
104.1	104.1	CD	B-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
completed	complete	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
during	during	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
low-grade	low-grade	JJ	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
frank	frank	NN	I-NP	O
fever	fever	NN	I-NP	O
over	over	IN	B-PP	O
100.4	100.4	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
subjective	subjective	JJ	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
self-discontinued	self-discontinued	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
test	test	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
passed	pass	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
consult	consult	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
and	and	CC	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
magnesium	magnesium	NN	I-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
and	and	CC	O	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
and	and	CC	O	O
1.1	1.1	CD	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	B-DNA
increasing	increase	VBG	I-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
from	from	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Mucomyst	Mucomyst	NNP	B-NP	O
prior	prior	RB	B-ADVP	O
and	and	CC	O	O
after	after	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
CCU	CCU	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
weakness	weakness	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
and	and	CC	O	O
MRI	MRI	NN	B-NP	O
and	and	CC	I-NP	O
MRA	MRA	NN	I-NP	B-protein
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

MRI/MRA	MRI/MRA	NN	B-NP	O
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
hypertension-induced	hypertension-induced	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
bubble	bubble	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
some	some	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
takes	take	VBZ	B-VP	O
Humalog	Humalog	NNP	B-NP	O
75/25	75/25	CD	I-NP	O
50	50	CD	I-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
Actos	Actos	NN	B-NP	O
and	and	CC	I-NP	O
metformin	metformin	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
with	with	IN	B-PP	O
14	14	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NovoLog	NovoLog	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
Lantus	Lantus	NNP	B-NP	O
35	35	CD	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
doses	dose	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
once	once	IN	B-SBAR	O
he	he	PRP	B-NP	O
goes	go	VBZ	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
PPI	PPI	NN	B-NP	B-protein
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
prolonged	prolonged	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
pending	pende	VBG	I-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-9330199	5-9330199	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Delmar	Delmar	NNP	B-NP	O
Rosebur	Rosebur	NNP	I-NP	O
Bustill	Bustill	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Hunt	Hunt	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Raul	Raul	NNP	B-NP	O
Bornmann	Bornmann	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Lau	Lau	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Sam	Sam	NNP	B-NP	O
Brownsberger	Brownsberger	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
Ph.D.	Ph.D.	NNP	B-NP	O
,	,	,	O	O
Anale	Anale	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MULLETT	MULLETT	NNP	B-NP	O
,	,	,	O	O
HAYWOOD	HAYWOOD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JONDLE	JONDLE	NNP	B-NP	O
,	,	,	O	O
MARY	MARY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9703848	9703848	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/25/05	5/25/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/25/05	5/25/05	CD	B-NP	O

